The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Uremia Alters HDL Composition and Function
Open accessAbstract
Functional impairment of HDL may contribute to the excess cardiovascular mortality experienced by patients with renal disease, but the effect of advanced renal disease on the composition and function of HDL is not well understood. Here, we used mass spectrometry and biochemical analyses to study alterations in the proteome and lipid composition of HDL isolated from patients on maintenance hemodialysis. We identified a significant increase in the amount of acute phase protein serum amyloid A1, albumin, lipoprotein-associated phospholipase A2, and apoC-III composing uremic HDL. Furthermore, uremic HDL contained reduced phospholipid and increased triglyceride and lysophospholipid. With regard to function, these changes impaired the ability of uremic HDL to promote cholesterol efflux from macrophages. In summary, the altered composition of HDL in renal disease seems to inhibit its cardioprotective properties. Assessing HDL composition and function in renal disease may help identify patients at increased risk for cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Comparison of Label-free Methods for Quantifying Human Proteins by Shotgun Proteomics
Old, W. M., Meyer-Arendt, K., Aveline-Wolf, L., Pierce, K. G., Mendoza, A., Sevinsky, J. R., Resing, K. A., & Ahn, N. G. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500084-mcp200 · Cited by 1,206
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
Himmelfarb, J., Stenvinkel, P., Ikizler, T. A., & Hakim, R. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00600.x · Cited by 1,179
Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26206 · Cited by 942
Role of apoCs in lipoprotein metabolism: functional differences between apoC1, apoC2, and apoC3
Jong, M. C., Hofker, M. H., & Havekes, L. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.472 · Cited by 539
HDL as a target in the treatment of atherosclerotic cardiovascular disease
Linsel-Nitschke, P., & Tall, A. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1658 · Cited by 486
Zalewski, A., & Macphee, C. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160551.21962.a7 · Cited by 474
Tall, A. R. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01898.x · Cited by 436
Coetzee, G. A., Strachan, A. F., van der Westhuyzen, D. R., Hoppe, H. C., Jeenah, M. S., & de Beer, F. C. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67562-3 · Cited by 426
Davidson, W. S., Silva, R. A. G. D., Chantepie, S., Lagor, W. R., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186031 · Cited by 415
Inflammation Impairs Reverse Cholesterol Transport In Vivo
McGillicuddy, F. C., de la Llera Moya, M., Hinkle, C. C., Joshi, M. R., Chiquoine, E. H., Billheimer, J. T., Rothblat, G. H., & Reilly, M. P. (2009) · Circulation · doi:10.1161/circulationaha.108.810721 · Cited by 391
High-density lipoprotein heterogeneity and function in reverse cholesterol transport
Rothblat, G. H., & Phillips, M. C. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328338472d · Cited by 340
Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
Stenvinkel, P. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02269.x · Cited by 332
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Ooi, E. M. M., Barrett, P. H. R., Chan, D. C., & Watts, G. F. (2008) · Clinical Science · doi:10.1042/cs20070308 · Cited by 282
Role of Serum Amyloid A During Metabolism of Acute-Phase HDL by Macrophages
Artl, A., Marsche, G., Lestavel, S., Sattler, W., & Malle, E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.763 · Cited by 254
Self-citationKarlsson, H., Leanderson, P., Tagesson, C., & Lindahl, M. (2005) · PROTEOMICS · doi:10.1002/pmic.200401010 · Cited by 241
Larrede, S., Quinn, C. M., Jessup, W., Frisdal, E., Olivier, M., Hsieh, V., Kim, M.-J., Van Eck, M., Couvert, P., Carrie, A., et al. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.194548 · Cited by 203
Investigation of an albumin‐enriched fraction of human serum and its albuminome
Gundry, R. L., Fu, Q., Jelinek, C. A., Van Eyk, J. E., & Cotter, R. J. (2007) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.200600276 · Cited by 194
Proteomic analysis of high‐density lipoprotein
Rezaee, F., Casetta, B., Levels, J. H. M., Speijer, D., & Meijers, J. C. M. (2006) · PROTEOMICS · doi:10.1002/pmic.200500191 · Cited by 174
Update on strategies to increase HDL quantity and function
Duffy, D., & Rader, D. J. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.94 · Cited by 169
HDL metabolism and activity in chronic kidney disease
Vaziri, N. D., Navab, M., & Fogelman, A. M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.36 · Cited by 163
Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux
Sankaranarayanan, S., Oram, J. F., Asztalos, B. F., Vaughan, A. M., Lund-Katz, S., Adorni, M. P., Phillips, M. C., & Rothblat, G. H. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800362-jlr200 · Cited by 162
Protein Carbamylation Renders High-Density Lipoprotein Dysfunctional
Holzer, M., Gauster, M., Pfeifer, T., Wadsack, C., Fauler, G., Stiegler, P., Koefeler, H., Beubler, E., Schuligoi, R., Heinemann, A., et al. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3640 · Cited by 159
Self-citationHDL-inflammatory index correlates with poor outcome in hemodialysis patients
Kalantar‐Zadeh, K., Kopple, J. D., Kamranpour, N., Fogelman, A. M., & Navab, M. (2007) · Kidney International · doi:10.1038/sj.ki.5002491 · Cited by 139
HDL Remodeling During the Acute Phase Response
Jahangiri, A., de Beer, M. C., Noffsinger, V. P., Tannock, L. R., Ramaiah, C., Webb, N. R., van der Westhuyzen, D. R., & de Beer, F. C. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178681 · Cited by 135
Washburn, M. P., Ulaszek, R. R., & Yates, J. R. (2003) · Analytical Chemistry · doi:10.1021/ac034120b · Cited by 121
Vaziri, N. D., Moradi, H., Pahl, M. V., Fogelman, A. M., & Navab, M. (2009) · Kidney International · doi:10.1038/ki.2009.177 · Cited by 114
Marsche, G., Heller, R., Fauler, G., Kovacevic, A., Nuszkowski, A., Graier, W. F., Sattler, W., & Malle, E. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000148703.43429.25 · Cited by 113
Self-citationAntiatherogenic Functionality of High Density Lipoprotein: How Much versus How Gooden-subtitle=
Sviridov, D., Mukhamedova, N., Remaley, A. T., Chin-Dusting, J. P. F., & Nestel, P. J. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e571 · Cited by 105
Lipid and lipoprotein metabolism in chronic kidney disease.
Kaysen, G. A. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.10.011 · Cited by 102
Marsche, G., Frank, S., Hrzenjak, A., Holzer, M., Dirnberger, S., Wadsack, C., Scharnagl, H., Stojaković, T., Heinemann, Á., & Oettl, K. (2009) · Circulation Research · doi:10.1161/circresaha.108.193169 · Cited by 98
Self-citationLipoprotein metabolism in chronic renal insufficiency
Saland, J. M., & Ginsberg, H. N. (2007) · Pediatric Nephrology · doi:10.1007/s00467-007-0467-5 · Cited by 87
von Eckardstein, A., Holz, H., Sandkamp, M., Weng, W., Funke, H., & Assmann, G. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115190 · Cited by 82
Stenvinkel, P. (2003) · Journal of Renal Nutrition · doi:10.1053/jren.2003.50018 · Cited by 78
Hirano, T., Sakaue, T., Misaki, A., Murayama, S., Takahashi, T., Okada, K., Takeuchi, H. T., Yoshino, G., & Adachi, M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00019.x · Cited by 57
Marsche, G., Frank, S., Raynes, J. G., Kozarsky, K., Sattler, W., & Malle, E. (2007) · Biochemical Journal · doi:10.1042/bj20061406 · Cited by 53
Self-citationApolipoprotein CIII and Atherosclerosis
Bobik, A. (2008) · Circulation · doi:10.1161/circulationaha.108.794081 · Cited by 53
ATP binding cassette G1-dependent cholesterol efflux during inflammation
de Beer, M. C., Ji, A., Jahangiri, A., Vaughan, A. M., de Beer, F. C., van der Westhuyzen, D. R., & Webb, N. R. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m012328 · Cited by 43
McCall, M. R., Belle, M. L., Forte, T. M., Krauss, R. M., Takanami, Y., & Tribble, D. L. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00177-5 · Cited by 42
Zhao, Y., Sparks, D. L., & Marcel, Y. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25145 · Cited by 37
Cited by
Unraveling the complexities of the HDL lipidome
Kontush, A., Lhomme, M., & Chapman, M. J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036095 · Cited by 396
Shah, A. S., Tan, L., Long, J. L., & Davidson, W. S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r035725 · Cited by 351
High-density lipoproteins: A consensus statement from the National Lipid Association
Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336
Ali, K. M., Wonnerth, A., Huber, K., & Wojta, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02081.x · Cited by 292
Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function
Stadler, J. T., & Marsche, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238985 · Cited by 200
Self-citation
Metadata
- Authors
- Holzer, M., Birner-Gruenberger, R., Stojakovic, T., El-Gamal, D., Binder, V., Wadsack, C., Heinemann, A., & Marsche, G.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2011-09
- Volume
- 22
- Issue
- 9
- Pages
- 1631-1641
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2140480769
- Cited by
- 268
- References
- 44
- FWCI
- 19.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.